Recent studies have shown the fluorescent treponemal antibody-cerebrospinal fluid (FTA-CSF) test to be the most sensitive of the serological tests investigated for the detection of treponemal antibody in cerebrospinal fluid (CSF) (Duncan and Kuhn, 1972; Duncan, Jenkins, and Parham, 1972) . The CSF specimens were obtained from humans with various stages of syphilis and from four chimpanzees before and at intervals after experimental infection with T. pallidum.
However, the question of a priori significance of the reactive FTA results in CSF still remains. When an immunologically broad spectrum conjugate is used, there is a probability of detecting treponemal IgG antibody, the origin of which may involve: (1) An equilibrium of antibody between the serum and CSF; (2) A damaged blood-brain barrier; (3) Local (CNS) production of antibody; (4) A combination of these.
Immunological studies of serum specimens by others have suggested that, since the IgM class of treponemal antibody supposedly appears earlier than that of the IgG class, the use of monospecific fluorescein labelled anti-IgM conjugate could result in earlier detection of the disease. Such a conjugate has been shown to be of value in differentiating passively transferred antibody from active syphilitic infection of the newborn (U.S. Department of Health, Education and Welfare, 1972) .
The IgM class of immunoglobulin is not considered to be a constituent of normal CSF (Schultze and Heremans 1966) . Under pathological conditions, however, IgM has been found in CSF associated with conditions of increased capillary permeability or local immunoglobulin production, including neurosyphilis (Laterre, Heremans, and Demanet, 1962; Oxelius, Rorsman, and Laurell, 1969) .
A method combining the sensitivity of the indirect
Received for publication April 13, 1973 fluorescent antibody (IFA) procedure and the specificity inherent in the use of a monospecific anti-IgM conjugate to detect a treponemal IgM antibody from within the CNS could be valuable in the early detection of neurosyphilis.
The purpose of the present study was to survey the occurrence of treponemal IgM antibody detectable by an IFA procedure in CSF specimens from humans infected with syphilis and from chimpanzees used as animal models for the study of the human disease.
Material and methods (1) Cerebrospinal fluid 370 CSF specimens were examined. A single CSF specimen was obtained from each of 29 humans in whom a diagnosis of neurosyphilis was made by the submitting physicians. Also, according to these physicians, nine of the individuals were thought to have been inadequately treated, twelve were thought to have been adequately treated, seven had received no antisyphilitic treatment, and on one no information was available.
The remaining 341 CSF samples were collected from 39 chimpanzees: 264 specimens were obtained sequentially from 24 chimpanzees before and up to 6 years after experimental infection with T. pallidum, 47 specimens were obtained sequentially from five chimpanzees before and up to 3 years after experimental infection with T. carateum, and thirty specimens were obtained from ten chimpanzees which were not experimentally infected although five of the animals did have naturally occurring treponemal serum antibody (Kuhn, Brown, and Falcone, 1968 (Hunter, 1971) . At least two lots of the anti-IgG conjugates were used in this study. The anti-IgM conjugate was found to be monospecific, and only one lot was used.
(3) Antigen
For the IFA tests a single lot of the improved Treponema pallidum antigen was used throughout the study (Hunter, Creighton, and Lewis, 1970) .
(4) Serological tests The FTA-CSF test was done as previously described (Duncan, Jenkins, and Parham, 1972 It is possible that none of the human specimens contained treponemal IgM antibody. Oxelius and others (1969) reported that IgM levels in CSF from individuals with neurosyphilis decreased after treatment; however, it was not shown that the antibody (Duncan, in preparation) . Link and Muller (1971) Kuhn, Tolliver, and Norins, 1970) .
The data from this study of the chimpanzee CSF specimens must, of course, be considered separately from those of the human material. In the first place the animals do not have clinical manifestations in the nervous system similar to man and we cannot categorize any of the animals as having neurosyphilis in spite of the fact that the CSF in some of the chimpanzees did exhibit polycytosis, increased CSF protein, and reactivity in the VDRL slide test. Secondly, some of the chimpanzee samples were obtained sequentially over a period of years when the chimpanzees were infected with other pathogenic treponemes, not necessarily T. pallidum.
The corresponding serum results from the two FTA-CSF IgM reactive chimpanzees are interesting (Table III) . Of fifteen CSF specimens tested, one (from No. 11) demonstrated treponemal IgM antibody, and the corresponding serum diluted in saline was reactive at a 1:1,600 dilution in the FTA-ABS IgM procedure. The undiluted CSF was reactive, but a 1:10 saline dilution was nonreactive. In a gel diffusion method to detect IgM antibody, the 1:800 dilution of serum produced a precipitation line but the undiluted CSF did not. Treponemes had been identified in this animal's CSF by direct FA staining with an anti-T. pallidum conjugate, and at that time a sample of CSF caused a syphilitic infection when inoculated into a rabbit.
Two other IgM reactive CSF specimens were from chimpanzee No. 23. The first specimen had a 'spider-web-like' coagulum, and the second did not. The first CSF was reactive in the FTA-CSF IgM test at a 1:10 dilution, the second specimen was reactive only when tested undiluted. The corresponding sera were reactive at dilutions of 1:100 and 1:1,600 respectively. The serum titre increased 16-fold and the CSF titre decreased to one-tenth the initial titre from the first to the second sampling. The first CSF specimen produced a precipitation line in the gel diffusion method, but the second specimen did not. Treponemal IgM antibody was not detected in subsequent specimens of CSF from this experimentally uninfected and untreated animal over a 5-year follow-up period.
From the results of this study it appears that an FTA-CSF IgM procedure on 
